Pages that link to "Q52869617"
Jump to navigation
Jump to search
The following pages link to Mild asymptomatic primary hyperparathyroidism is not a risk factor for vertebral fractures. (Q52869617):
Displaying 50 items.
- Catabolic and anabolic actions of parathyroid hormone on the skeleton (Q26828873) (← links)
- Primary hyperparathyroidism: whole-body bone mineral density in surgically treated Danish patients: a three-year follow-up study. (Q30818455) (← links)
- Effects of oral alendronate in elderly patients with osteoporosis and mild primary hyperparathyroidism (Q31811778) (← links)
- Bone mineral content in patients with primary hyperparathyroidism: a comparison of conservative management with surgical treatment (Q33209088) (← links)
- Overview of osteoporosis. (Q33558820) (← links)
- Treatment induced changes of bone density and relative risk of vertebral fracture (Q33757735) (← links)
- Primary hyperparathyroidism: pathophysiology and impact on bone (Q33954167) (← links)
- Natural history of primary hyperparathyroidism (Q34061503) (← links)
- Primary hyperparathyroidism. When to observe and when to operate (Q34061508) (← links)
- Role of surgery in mild primary hyperparathyroidism in the elderly (Q34106895) (← links)
- Bone status in primary hyperparathyroidism (Q34233589) (← links)
- Clinical spectrum of primary hyperparathyroidism (Q34437547) (← links)
- Rheumatic manifestations of primary hyperparathyroidism and parathyroid hormone therapy (Q34560748) (← links)
- Clinical evaluation for osteoporosis (Q35198531) (← links)
- Primary hyperparathyroidism: aggressive or conservative treatment? (Q35478996) (← links)
- Morphometric vertebral fractures in postmenopausal women with primary hyperparathyroidism (Q35544592) (← links)
- Primary hyperparathyroidism: new concepts in clinical, densitometric and biochemical features (Q35987835) (← links)
- The diagnosis and management of asymptomatic primary hyperparathyroidism (Q36587575) (← links)
- Asymptomatic primary hyperparathyroidism (Q36658921) (← links)
- Current pharmacological options for the management of primary hyperparathyroidism (Q36669632) (← links)
- Diagnosis and management of asymptomatic hyperparathyroidism: safety, efficacy, and deficiencies in our knowledge (Q36884945) (← links)
- Surgical therapy of patients with primary hyperparathyroidism: long-term benefits (Q36884951) (← links)
- Interpretation of bone mass determinations as they relate to fracture: Implications for asymptomatic primary hyperparathyroidism (Q36885011) (← links)
- Asymptomatic hyperparathyroidism--need for multicentre studies. (Q36891113) (← links)
- Primary hyperparathyroidism and the skeleton (Q37048218) (← links)
- Cohort study of risk of fracture before and after surgery for primary hyperparathyroidism. (Q37354358) (← links)
- Endocrine Causes of Bone Disease (Q40472421) (← links)
- "Asymptomatic" and symptomatic primary hyperparathyroidism (Q40847455) (← links)
- Clinical utility of bone mass measurements in adults: consensus of an international panel. The Society for Clinical Densitometry (Q40937824) (← links)
- Consensus of an international panel on the clinical utility of bone mass measurements in the detection of low bone mass in the adult population (Q40945372) (← links)
- Maintenance of cancellous bone connectivity in primary hyperparathyroidism: trabecular strut analysis (Q41101378) (← links)
- PTHrP(1-36) as a skeletal anabolic agent for the treatment of osteoporosis (Q41190113) (← links)
- The skeletal effects of primary hyperparathyroidism (Q41530932) (← links)
- Bone structure in postmenopausal hyperparathyroid, osteoporotic, and normal women (Q41659836) (← links)
- Bone mass is related to creatinine clearance in normal elderly women (Q41818161) (← links)
- Nontraumatic Multiple Vertebral Compression Fractures Induced by Primary Hyperparathyroidism: A Case Report and Literature Review (Q50203803) (← links)
- Primary hyperparathyroidism: biochemical markers and bone mineral density at multiple skeletal sites in Danish patients (Q50560758) (← links)
- Bone histomorphometry and serum concentrations of intact parathyroid hormone (PTH(1-84)) in patients with primary hyperparathyroidism. (Q51598051) (← links)
- Classification of dynamical diseases by new mathematical tools: application of multi-dimensional phase space analyses to the pulsatile secretion of parathyroid hormone (Q52420043) (← links)
- New observations on bone quality in mild primary hyperparathyroidism as determined by quantitative backscattered electron imaging. (Q53501557) (← links)
- Bone measurements in asymptomatic primary hyperparathyroidism. (Q54137196) (← links)
- Hyperparathyroidism (Q56428518) (← links)
- Longitudinal changes in forearm bone mineral content in primary hyperparathyroidism (Q67808871) (← links)
- Asymptomatic primary hyperparathyroidism discovered by multichannel biochemical screening: Clinical course and considerations bearing on the need for surgical intervention (Q67808877) (← links)
- Primary hyperparathyroidism: Epidemiology, diagnosis and clinical picture (Q67818330) (← links)
- Trabecular bone mineral density in primary hyperparathyroidism: relationship to clinical presentation and biomarkers of skeletal turnover (Q70610442) (← links)
- Primary hyperparathyroidism (Q72532449) (← links)
- Three-dimensional analysis of the spine in autopsy cases with renal osteodystrophy (Q72898089) (← links)
- Parathyroidectomy for asymptomatic primary hyperparathyroidism (PHPT): is it worth the risk? (Q73661030) (← links)
- Changes in bone mass and serum markers of bone metabolism after parathyroidectomy (Q73880749) (← links)